Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35235

A clinical study for patients with Ulcerative Colitis

Birmingham Alabama 35294-3300

A clinical trial seeking patients for a Crohn's Disease treatment research study

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

UPDATED

Dothan Alabama 36305

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Huntsville Alabama 35801

A clinical study for patients with Ulcerative Colitis

View More ▼

Huntsville Alabama 35801

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mobile Alabama 36617

A clinical study for patients with Ulcerative Colitis

Mobile Alabama

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Arizona

Phoenix Arizona 85016

A clinical trial seeking patients for a Crohn's Disease treatment research study

UPDATED

Phoenix Arizona

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

Phoenix Arizona

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Phoenix Arizona

A Phase 4 clinical study for patients with Inflammatory Bowel Disease

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating LT-02 and LT-02 Placebo for the treatment of Ulcerative Colitis

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease, Mild to Moderate

View More ▼

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Beverly Hills California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Chula Vista California 91910

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

Coronado California 92118

A clinical study for patients with Ulcerative Colitis

Encinitas California 92024

A clinical study for patients with Ulcerative Colitis

View More ▼

UPDATED

Garden Grove California

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Mirada California

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Lancaster California 93534

Patients are needed to participate in a clinical research study evaluating LT-02 and LT-02 Placebo for the treatment of Ulcerative Colitis

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 90048

A clinical trial seeking patients for a Crohn's Disease treatment research study

UPDATED

Los Angeles California 90045

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Los Angeles California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Los Angeles California

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Newport Beach California

Patients are needed to participate in a clinical research study evaluating Placebo IV, Placebo SC, Ustekinumab IV and Ustekinumab SC for the treatment of Colitis, Ulcerative or Inflammatory Bowel Diseases

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Oakland California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Orange California 92868

A clinical study for patients with Ulcerative Colitis

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease